We determined whether the synthesized ZnPcS could be injected intraperitoneally to pass through the BBB and accurately suppress glioma and whether ZnPcS accurately targets glioma through SPARC in vivo and in vitro. This evidence concerns the gene SPARC and central nervous system cancer.